Decheng Capital

Decheng Capital is a global life sciences investment firm founded in 2012. It focuses on early-stage life science companies and growth-stage healthcare companies, with over $2.5 billion in assets under management. The firm has offices in Silicon Valley, Shanghai, and New York. Decheng Capital's investment strategy emphasizes cross-border opportunities, particularly between the United States and China. They invest in sectors such as biopharma, diagnostics and tools, medical devices, and healthcare services.